Abstract
The conformation of a peptide defines its antigenic specificity. In most cases, a free peptide is in a random form, whereas the same peptide within a protein hasa defined conformation. Immunological cross-reactions between the two are rare. Nevertheless, there are cases where an anticonformational antibody may transconform (change the conformation of) the free peptide, allowing the reaction to occur.
Based on such considerations, synthetic vaccines against infectious diseases may be constructed. The same is true for autoimmune diseases, where, at least in one case—that of the exacerbating-remitting type of multiple sclerosis— we have developed a polypeptidic drug-vaccine, copolymer 1 (denoted Copaxone), capable of suppressing the autoimmune phenomena in a specific way. This drug-vaccine has been approved for treatment by the US Food and Drug Administration (FDA).
Similar content being viewed by others
References
Sela, M. (1969), Science 166, 1365–1374.
Sela, M., Schechter, B., Schechter, I., and Borek, F. (1967), Cold Spring Harbor Symp. Quant. Biol. 32, 537–545.
Schechter, B., Schechter, I., Ramachandran, J., Conway-Jacobs, A., Sela, M., Benjamini, E., and Shimizu, M. (1971), Eur. J. Biochem. 20, 309–320.
Schechter, B., Schechter, I., Ramachandran, J., Conway-Jacobs, A., and Sela, M. (1971), Eur. J. Biochem. 20, 301–308.
Schechter, B., Conway-Jacobs, A., and Sela, M., (1971). Eur. J. Biochem. 20, 321–324.
Arnon, R., Maron, E., Sela, M., and Anfinsen, C. B. (1971), Proc. Natl. Acad. Sci. USA 68, 1450–1454.
Langbeheim, A., Arnon, R., and Sela, M. (1976), Proc. Natl. Acad. Sci. USA 73, 4636–4670.
Sela, M., and Arnon, R. (1992), Vaccine 10, 991–999.
Audibert, F., Jolivet, M., Chedid, L., Alouf, J. F., Bouquet, P., and Siffret, O. (1981), Nature 289, 593–595.
Jacob, C. O., Sela M., and Arnon, R. (1983), Proc. Natl. Acad. Sci. USA 80, 7611–7615.
Arnon, R., Sela, M., Parent, M., and Chedid, L. (1980), Proc. Natl. Acad. Sci. USA 77, 6769–6772.
Audibert F., Jolivet, M., Chedid, L., Arnon, R., and Sela M. (1982), Proc. Natl. Acad. Sci. USA 79, 5042–5046.
Jacob, C. O., Arnon, R., and Sela, M. (1986), Immunol. Lett. 14, 43–48.
Teitelbaum, D., Meshorer, A., Hirshfeld, T., Arnon, R., and Sela, M. (1971), Eur. J. Immun. 1, 242–248.
Sela, M., Arnon, R., and Teitelbaum, D. (1990), Bull. Inst. Pasteur 88, 303–314.
Teitelbaum, D., Arnon, R., and Sela, M. (1997), CMLS, Cell. Mol. Life Sci. 53, 24–28.
Teitelbaum, D., Sela, M., and Arnon, R. (1997), Israel J. Med. Sci. 33, 280–284.
Teitelbaum, D., Aharoni, R., Sela, M., and Arnon, R. (1991), Proc. Natl. Acad. Sci. USA 88, 9528–9532.
Webb, C., Teitelbaum, D., Arnon, R., and Sela, M. (1973), Eur. J. Immunol. 3, 273–279.
Webb, C., Teitelbaum, D., Herz, A., Arnon, R., and Sela, M. (1976), Immunochemistry 13, 333–337.
Aharoni, R., Teitelbaum, D., and Arnon, R. (1993), Eur. J. Immunol. 23, 17–25.
Aharoni, R., Teitelbaum, D., Sela, M., and Arnon, R. (1997), Proc. Natl. Acad. Sci. USA 94, 10821–10826.
Aharoni, R., Teitelbaum, D., Arnon, R., and Sela, M. (1999), Proc. Natl. Acad. Sci. USA, in press.
Bornstein, M. B., Miller, A., Slagle, S., Weitzman, M., Crystal, H., Drexler, E., Keilson, M., Merriam, A., Wassertheil-Smoller, S., Spada, V., Weiss, W., Arnon, R., Jacobsohn, I., Teitelbaum, D., and Sela, M. (1987), N. Engl. J. Med. 317, 408–414.
Johnson, K. P., Brooks, B. R., Cohen, J. A., Ford, C. C., Goldstein, J., Lisak, R. P., Myers, L. W., Panitsch, H. S., Rose, J. W., Schiffer, R. B., Vollmer, T., Weiner, L. P., Wolinsky, J. S., and The Copolymer 1 Multiple Sclerosis Study Group (1995), Neurology 45, 1268–1276.
Johnson, K. P., Brooks, B. R., Cohen, J. A., Ford, C. C., Goldstein, J., Lisak, R. P., Myers, L. W., Panitsch, H. S., Rose, J. W., Schiffer, R. B., Vollmer, T., Weiner, L. P., Wolinsky, J. S., and The Copolymer 1 Multiple Sclerosis Study Group (1995), Neurology 50, 701–708.
Zisman, E., Katz-Levy, Y., Dayan, M., Kirshner, S. L., PaasRozner, M., Karni, A., Abramsky, O., Brautbar, Ch., Fridkin, M., Sela, M., and Mozes, E. (1996), Proc. Natl. Acad. Sci. USA 93, 4492–4497.
Katz-Levy, Y., Paas-Rozner, M., Kirshner, S., Dayan, M., Zisman, E., Fridkin, M., Wirguin, I., Sela, M., and Mozes, E. (1997), Proc. Natl. Acad. Sci. USA 94, 3200–3205.
Katz-Levy, Y., Dayan, M., Wirguin, I., Fridkin, M., Sela, M., and Mozes, E. (1998), J. Neuroimmunol. 85, 78–86.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sela, M. Structural components responsible for peptide antigenicity. Appl Biochem Biotechnol 83, 63–70 (2000). https://doi.org/10.1385/ABAB:83:1-3:63
Issue Date:
DOI: https://doi.org/10.1385/ABAB:83:1-3:63